Free Annual ReportsKYTHERA Biopharmaceuticals Inc $ 42.21
+0.26
Digital Company Profile
| Last Trade: | 42.21 |
| Trade Time: | Sep 18 04:00 PM Eastern Daylight Time |
| Change: | 0.26 (0.63 %) |
| Prev Close: | 41.95 |
| Open: | 43.12 |
| Bid: | 42.21 |
| Ask: | 42.42 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get KYTH Trend Analysis
-
it has outperformed the S&P 500 by 95%
ETF Alternatives
| Ticker | Name | Weight | % Change |
|---|---|---|---|
| No ETF alternatives available. | |||
Competitors
| Ticker | Name | Volume | % Change |
|---|---|---|---|
| PFE | Pfizer Inc | 30.22M | +1.40% |
| MRK | Merck & Co Inc | 14.01M | +0.81% |
| BMY | Bristol Myers Squibb Co | 10.39M | +2.47% |
| JNJ | Johnson & Johnson | 10.09M | +0.95% |
| ELTP | Elite Pharmaceuticals Inc | 9.90M | +21.50% |
Insider Transactions
| Date | Name | Title | Volume | Trade Price | Holding Change |
|---|---|---|---|---|---|
| 9/10/2013 | Klein Keith | General Counsel | -183 | $32.00 | -100.00% |
| 9/10/2013 | David Nathaniel E | Director | -3,188 | $32.00 | -0.60% |
| 9/10/2013 | Smither John W | Chief Financial Officer | -30,000 | $30.03 | -100.00% |
| 9/09/2013 | Klein Keith | General Counsel | -4,317 | $32.00 | -100.00% |
| 9/09/2013 | David Nathaniel E | Director | -3,188 | $30.00 | -0.60% |
Data provided by Insiderslab.com.
To read detailed Insider Trading Research Report for (
KYTH ), click here.
KYTH Stock Analysis
- No results found.
-
Free Managed Futures Book
Get the four benefits of managed futures as outlined in this booklet. -
View the Portfolios of the Worlds Top Investors, FREE!
Learn from Warren Buffett, George Soros and More! -
7 Proven Strategies for Market-Stomping Stocks
Discover Investing Strategies that will Benefit Every Investor Today!
Free Annual Reports